Cited by 126Dendrimers and Hyperbranched PolymersNanoparticle-Based Drug DeliveryImmunotherapy and Immune Responses

Recent advances in dendrimer-based nanoplatform for cancer treatment: A review

Ambekar, Rushikesh S., Choudhary, Maya, Kandasubramanian, Balasubramanian·2020·European Polymer Journal

Integrity signals

Registry

Crossref · 10.1016/j.eurpolymj.2020.109546

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Drug resistance, toxicity, and the mechanics of drug release in capsules can all be overcome using dendrimers, making them ideal systems as smart nanoparticles for cancer therapy.

    “Drug resistance, toxicity, and the mechanics of drug release in capsules can all be overcome using dendrimers, which make them ideal systems as smart nanoparticles for cancer therapy.34”

    From Smart nanoparticles for cancer therapy (2023) · cites this paper as [34]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ambekar, R. S., Choudhary, M., & Kandasubramanian, B.
Affiliations
  • Indian Institute of Technology Kharagpur (IN)
  • University of Rajasthan (IN)
  • Defence Institute of Advanced Technology (IN)
Corresponding author
Kandasubramanian, Balasubramanian
Venue
European Polymer Journal
Publisher
Elsevier BV
Published
2020-03
Volume
126
Pages
109546
ISSN
0014-3057 (ISSN-L)
OpenAlex
W3004592562
Cited by
126
References
98
Citations by year
2026: 9 · 2025: 18 · 2024: 19 · 2023: 18 · 2022: 19 · 2021: 28 · 2020: 15
FWCI
1.24
Type
journal article
Language
en
Open access
closed
Locations
European Polymer Journal (publishedVersion)
Topics
  • Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
dendrimers, anticancer drug delivery, drug carriers, PEGylation, biocompatibility, targeting ligands, doxorubicin, cisplatin, paclitaxel, methotrexate, gold nanoparticles, iron oxide nanoparticles, drug release mechanism, dendrimer synthesis, targeted cancer therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review